Flux Power Holdings Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Flux Power Holdings Inc trades at $0.47 (market cap $9.97M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2534.6× Flux Power Holdings Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| FLUX | RPRX | |
|---|---|---|
Market Cap | $9.97M | $25.27B |
Volume | 817,320 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $6.66 | $63.96 |
52-Week Low | $0.41 | $35.44 |
Typical Hold Time | 20 Days | 1 Days |
Enterprise Value | $18.18M | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.461, down 5.96% today, amid a bearish technical signal and weak earnings. Revenue fell to $42M in 2026 with a net loss of $7M, though the P/S ratio of 0.22 suggests undervaluation. The company rejected an unsolicited acquisition proposal from Solidion Technology in October 2026, adding uncertainty. Analyst consensus remains unanimously bullish with 6 buy ratings, contrasting with negative profitability metrics like a -17.68% net income margin.
The outlook is mixed: strong analyst support and low valuation multiples offer potential upside if execution improves, but persistent losses, declining revenue, and acquisition resistance pose significant risks. Investors should weigh the bullish sentiment against fundamental weaknesses and recent volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →